Want to join the conversation?
$URI 2Q15 Call: We generated free cash flow of $432MM that includes $2MM of merger-related payments & that compares to $240MM on a comparable basis for first six months of 2014. The driver of the increase was largely a result of the YoverY improvement in EBITDA performance with some benefits in other lines including a variety of other items.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)